To view this email as a web page, click here.

Wound Healing
Therapy for blistering condition moves to next stage
FCX-007 could be the first major medical advance for recessive dystrophic epidermolysis bullosa, or RDEB, in decades.
Learn more.
ADVERTISEMENT
 
Look beyond diagnosis to see beauty and humanity
Rick Guidotti, founder of the not-for-profit organization Positive Exposure, says his message for dermatologists is simple: See patients as people first.
Learn more.
ADVERTISEMENT
 
Pipeline topical reduces epidermolysis bullosa blistering
Castle Creek Pharmaceuticals announced in June 2017 that the first patient had enrolled in its phase 2/3 study assessing the safety and efficacy of its pipeline diacerein 1% ointment to treat epidermolysis bullosa simplex.
Learn more.
 
In case you missed it
 
The future of wound healing
Experimental 3D printer turns small biopsy into ample skin cells to cover extensive wounds.
Learn more.
 
Wound healing and the HS patient
Draining lesions call for specialized attention.
Learn more.
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.